Author: OurCrowd

OurCrowd’s portfolio company MedAware featured in Globes

Oct 2, 2014 | ,

OurCrowd portfolio company MedAware was featured in Globes, the leading Israeli financial daily. Medication errors greatly affect a vast number of people and institutions, harming an estimated 1.5 million Americans each year. Medaware seeks to provide better preventative services than other prescription reviewing systems. MedAware has developed an innovative software-based solution that combines the power of big data analytics and machine learning to save lives and reduce medical costs by combating prescription errors. MedAware Co-Founder and CEO Gidi Stein said, “Three years ago I came across a tragic case of a nine-year-old Israeli boy who died because his primary-care physician accidentally prescribed the wrong drug. The ease with which a little boy died because of a mistaken click of a button was horrifying to me as a physician and as a parent. We have founded MedAware in order to try and prevent such cases.” MedAware raised $1 million from GE Ventures and OurCrowd investors in 2014. Read more on...

Read More
[PRESS RELEASE] OurCrowd’s Portfolio Company ReWalk Launches IPO on NASDAQ

[PRESS RELEASE] OurCrowd’s Portfolio Company ReWalk Launches IPO on NASDAQ

Sep 30, 2014 |

Jerusalem, Israel September 30, 2014: OurCrowd, the leading equity crowdfunding platform for accredited investors, announced today that its portfolio company ReWalk Robotics (RWLK) has completed its successful IPO on the NASDAQ. The company issued 3,450,000 million shares and expects to receive total estimated net proceeds from this offering of approximately $36.3 million after deducting estimated underwriting discounts and commissions and estimated offering expenses.  Read more...

Read More
[PRESS RELEASE] OurCrowd’s Portfolio Company ReWalk Launches IPO on NASDAQ

[PRESS RELEASE] OurCrowd’s Portfolio Company ReWalk Launches IPO on NASDAQ

Sep 30, 2014 |

Jerusalem, Israel September 30, 2014: OurCrowd, the leading equity crowdfunding platform for accredited investors, announced today that its portfolio company ReWalk Robotics (RWLK) has completed its successful IPO on the NASDAQ. The company issued 3,450,000 million shares and expects to receive total estimated net proceeds from this offering of approximately $36.3 million after deducting estimated underwriting discounts and commissions and estimated offering expenses.  Read more...

Read More

[Crowdfund Insider] OurCrowd’s Portfolio Company ReWalk Successfully Launches IPO on NASDAQ

Sep 30, 2014 |

“OurCrowd’s CEO Jon Medved says, ‘OurCrowd is proud of ReWalk and this important achievement. We have now demonstrated that equity crowdfunding can provide an opportunity for individual accredited investors to fund the best of companies. This offering marks the first time an equity crowdfunding platform has accompanied a company over the full cycle, from venture funding through to an IPO on a major US exchange. Moreover, it is truly gratifying to invest in successful companies that dramatically change people’s lives for the better.’...

Read More

[TechCrunch] With Plans of Investing $100M Next Year, Israel’s OurCrowd Forges Its Own Path in Equity Crowdfunding

Sep 26, 2014 |

“OurCrowd, which is run by serial entrepreneur and venture capitalist Jon Medved, has put at least $70 million to work in roughly 50 companies and has plans to invest $100 million more over the next year. One of their companies, ReWalk Robotics, an exoskeleton company that helps disabled people walk again, just IPO-ed a little over week ago and now has a market cap of about $360...

Read More